Gradient Biomodeling
Gradient Biomodeling, LLC has developed a versatile computational platform for modeling biomolecular interactions and pathways. Their technology is applied in drug discovery and design, therapeutic compound repositioning, small-molecule diagnostics, chemical genetics, and biomarker identification. The company's innovative approach includes Metric Modeling utilizing adaptive machine-learning algorithms for predictive similarity measures and a proprietary Quantum Representation of molecules. They have announced collaborations with Janssen Pharmaceutica NV and the Huntsman Cancer Institute, and have provisional patent applications related to drug compounds. Gradient Biomodeling's platform aims to shorten timelines and reduce costs in early-stage drug development.
Gradient Biomodeling
Gradient Biomodeling, LLC has developed a versatile computational platform for modeling biomolecular interactions and pathways. Their technology is applied in drug discovery and design, therapeutic compound repositioning, small-molecule diagnostics, chemical genetics, and biomarker identification. The company's innovative approach includes Metric Modeling utilizing adaptive machine-learning algorithms for predictive similarity measures and a proprietary Quantum Representation of molecules. They have announced collaborations with Janssen Pharmaceutica NV and the Huntsman Cancer Institute, and have provisional patent applications related to drug compounds. Gradient Biomodeling's platform aims to shorten timelines and reduce costs in early-stage drug development.